AbbVie

In the last 7 days

Drug company files suit against South Dakota over new 340B law South Dakota Public Broadcasting12:44 16-Apr-25

The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment Zacks10:44 16-Apr-25

Top Research Reports for AbbVie, TJX & Charles Schwab Zacks22:31 15-Apr-25

AbbVie Asks Court to Extend Venclexta Cancer-Drug Patent’s Life Bloomberg Law17:35 15-Apr-25

The Zacks Analyst Blog Merck and AbbVie Zacks13:00 15-Apr-25

ThirtyFiveBio Closes Bridge Round of Financing Highlighted by Strategic New Investment from… PR Newswire (Press Release)12:00 15-Apr-25

Rosen, A leading investor rights law firm, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel… GlobeNewswire (Press Release)22:52 14-Apr-25

AbbVie and Sandoz resolve court spat over Rinvoq patents ENDPOINTS20:30 14-Apr-25

ABBV vs. MRK: Which Drug Giant is a Better Buy Now? Zacks16:49 14-Apr-25

Earnings Preview: What to Expect From AbbVie's Report Barchart10:41 14-Apr-25

The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis Zacks08:20 14-Apr-25

Mastopexy Market Share Analysis and Forecast Report 2025-2033 Featuring Abbvie, Allergan,… Business Wire (Press Release)07:45 14-Apr-25

Block, Simon, Sirius, AbbVie, Apple: Trending by Analysts TipRanks10:02 12-Apr-25

AbbVie, Sandoz Settle Patent Fight Over Rinvoq Generics Law36000:11 12-Apr-25

AbbVie Brings New Suits Against State Pharmacy Contract Laws Bloomberg Law18:56 11-Apr-25

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On… Benzinga09:42 11-Apr-25

AbbVie Wants ND, SD Drug Pricing Laws Blocked Law36004:29 11-Apr-25

In the last month

Antiviral Drugs Market Forecasts and Company Analysis 2025-2034 Featuring AbbVie, Aurobindo, BMS, Cipla, Dr. Reddy's,… GlobeNewswire (Press Release)15:03 10-Apr-25

AbbVie Stock Up 9.2% After Key Signal Benzinga13:00 10-Apr-25

AbbVie: Thriving Beyond Humira's Patent Cliff (Upgrade) Seeking Alpha23:56 9-Apr-25

Rosen Law Firm Urges Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Stockholders to Contact … Business Wire (Press Release)17:07 9-Apr-25

AbbVie’s Rinvoq receives EC approval to treat adults with giant cell arteritis PMLiVE12:32 9-Apr-25

AbbVie’s upadacitinib gains EU marketing authorisation for GCA Pharmaceutical Technology09:46 9-Apr-25

AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis Zacks15:17 8-Apr-25

Rinvoq cleared for giant cell arteritis in EU, ahead of US pharmaphorum12:28 8-Apr-25

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of… PR Newswire (Press Release)07:03 8-Apr-25

AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting Simply Wall St19:57 7-Apr-25

Salesforce, Block, AbbVie, Applied Materials, Oracle: Insider Moves Unveiled TipRanks14:06 5-Apr-25

AbbVie Says Aurobindo's Rinvoq Generic Infringes Patent Law36003:26 5-Apr-25

AstraZeneca, AbbVie Lose Minnesota Contract Pharmacy Law Suit Bloomberg Law18:24 4-Apr-25

AbbVie cuts 2025 profit forecast on acquisition expenses Yahoo! US21:42 3-Apr-25

Gastric Cancer Research Report 2025: A $14.5 Billion Market by 2032, Growing with a CAGR of 13% Featuring AstraZeneca,… GlobeNewswire (Press Release)09:06 3-Apr-25

Esophageal Cancer Market research 2024-2032 Featuring AstraZeneca, Takeda, Pfizer, Novartis, Amgen, Bristol-Myers… GlobeNewswire (Press Release)09:06 3-Apr-25

AbbVie Fights Mississippi Drug Discount Law at Fifth Circuit Bloomberg Law20:17 2-Apr-25

AbbVie On A STEAP Learning Curve In ADCs Scrip Pharma Intelligence17:11 2-Apr-25

AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold? Barchart16:19 2-Apr-25

Looking At AbbVie's Recent Unusual Options Activity Nasdaq20:58 1-Apr-25

Gubra’s AbbVie-partnered amylin looks competitive with Zealand’s in early trial ENDPOINTS15:46 1-Apr-25

AbbVie: Margin Expansion Potential Can Support Elevated P/E Seeking Alpha00:52 1-Apr-25

AbbVie to Host First-Quarter 2025 Earnings Conference Call PR Newswire (Press Release)13:08 31-Mar-25

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others ENDPOINTS05:05 31-Mar-25

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 PR Newswire (Press Release)12:32 26-Mar-25

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income The Motley Fool10:35 26-Mar-25

AbbVie sues Genmab, claiming trade secrets theft pharmaphorum09:17 25-Mar-25

AbbVie and Genmab: Can a legal battle break a billion-dollar bond? Labiotech08:09 25-Mar-25

AbbVie files suit against Genmab subsidiary ProfoundBio ENDPOINTS19:11 24-Mar-25

Genmab to Defend Against AbbVie’s Trade Secret Misappropriation Claims TipRanks12:51 24-Mar-25

Nvidia, Exxon, AbbVie, Uber, Adobe: Insider Moves Unveiled TipRanks13:01 22-Mar-25

Genmab Refutes Trade Secret Claims in Complaint by AbbVie Bloomberg Law04:34 22-Mar-25

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. GlobeNewswire (Press Release)03:29 22-Mar-25

Aquipta hailed as game-changer in migraine prevention at AbbVie symposium Korea Biomedical Review05:55 21-Mar-25

Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends The Motley Fool13:32 20-Mar-25

Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer American Journal of Managed Care13:18 20-Mar-25

AbbVie’s Elahere shows consistent survival benefits in late-stage ovarian cancer trial PMLiVE12:31 19-Mar-25

Big pharma fears best-selling Irish drugs in crosshairs of Trump tariffs BreakingNews.ie13:51 18-Mar-25

view more headlines

16 Apr 12:44

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.